Telo Genomics Corp Stock Analysis

Telo Stock Analysis Notes

The company recorded a loss per share of 0.04. Telo Genomics Corp last dividend was issued on the 22nd of November 2019. The entity had 1:5 split on the 22nd of November 2019. Telo Genomics Corp., a personalized medicine company, focuses on the development and commercialization of predictive technological products. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. TELO GENOMICS operates under Diagnostics Research classification in Canada and is traded on TSX Venture Exchange. To find out more about Telo Genomics Corp contact the company at 416 673 8487 or learn more at https://www.telodx.com.

Telo Genomics Corp Investment Alerts

Telo Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.57 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Telo Genomics's market, we take the total number of its shares issued and multiply it by Telo Genomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Telo Profitablity

Management Efficiency

Telo Genomics Corp has return on total asset (ROA) of (0.8732) % which means that it has lost $0.8732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6942) %, meaning that it generated substantial loss on money invested by shareholders. Telo Genomics' management efficiency ratios could be used to measure how well Telo Genomics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.12 in 2024. Return On Capital Employed is likely to climb to -0.13 in 2024. At this time, Telo Genomics' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 3.4 M in 2024, whereas Intangible Assets are likely to drop slightly above 520.3 K in 2024.

Technical Drivers

As of the 18th of December 2024, Telo Genomics has the Risk Adjusted Performance of (0.01), variance of 61.14, and Coefficient Of Variation of (3,257). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telo Genomics Corp, as well as the relationship between them. Please validate Telo Genomics Corp value at risk, skewness, and the relationship between the maximum drawdown and potential upside to decide if Telo Genomics is priced more or less accurately, providing market reflects its prevalent price of 0.12 per share.

Telo Genomics Corp Price Movement Analysis

Telo Genomics Outstanding Bonds

Telo Genomics Predictive Daily Indicators

Telo Genomics Forecast Models

Telo Genomics' time-series forecasting models are one of many Telo Genomics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telo Genomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Telo Genomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telo Genomics. By using and applying Telo Stock analysis, traders can create a robust methodology for identifying Telo entry and exit points for their positions.

When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.